Survival Outcomes in Sinonasal Poorly Differentiated Squamous Cell Carcinoma
- PMID: 32959912
- DOI: 10.1002/lary.29090
Survival Outcomes in Sinonasal Poorly Differentiated Squamous Cell Carcinoma
Abstract
Objective: Sinonasal squamous cell carcinoma (SCC) is rare with no consensus on treatment regimen. Our goal is to analyze treatment outcomes in poorly differentiated SCC (PDSCC) using a large national database.
Study design: Retrospective database study.
Methods: The National Cancer Database was queried for sinonasal invasive SCC, grade 3 (poorly differentiated) from 2004 to 2014. Patient demographics and tumor and treatment characteristics were tabulated. Kaplan-Meier (KM) analysis was performed to compare overall survival (OS) between histology subtype and primary site. Multivariable Cox proportional hazards regression was performed for statistical analysis of treatment regimen on OS.
Results: A total of 1,074 patients were identified. The maxillary sinus was the most common site (45%). T4 tumors were observed in 50% of patients, with most patients treated at high-volume facilities (77%). In KM analysis, spindle cell SCC histological subtype, primary tumors of the maxillary sinus, and poorly differentiated grade had worse OS. In our Cox-PH model, higher T stage and age were associated with worse OS. Those treated at a high-volume facility and those who underwent surgical resection followed by adjuvant radiation had improved OS. Chemotherapy within the treatment regimen did not confer survival benefit except in surgical patients when positive margins were present, and surgery with adjuvant chemoradiation trended toward improved survival.
Conclusions: Sinonasal PDSCC appears to be best treated at high-volume centers with surgical resection followed by adjuvant radiation. Poorly differentiated grade has worse OS compared to more differentiated tumors. Chemotherapy along with adjuvant radiation may have a role in patients with positive surgical margins.
Level of evidence: 4 Laryngoscope, 131:E1040-E1048, 2021.
Keywords: National Cancer Database; Sinonasal malignancy; poorly differentiated squamous cell carcinoma; survival outcomes.
© 2020 American Laryngological, Rhinological and Otological Society Inc, "The Triological Society" and American Laryngological Association (ALA).
Similar articles
-
Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?Otolaryngol Head Neck Surg. 2020 Nov;163(5):986-991. doi: 10.1177/0194599820935395. Epub 2020 Jun 30. Otolaryngol Head Neck Surg. 2020. PMID: 32600116
-
Margins in Sinonasal Squamous Cell Carcinoma: Predictors, Outcomes, and the Endoscopic Approach.Laryngoscope. 2020 Jun;130(6):E388-E396. doi: 10.1002/lary.28315. Epub 2019 Nov 22. Laryngoscope. 2020. PMID: 31755988
-
Choice of Adjuvant Radiotherapy Facility in Sinonasal Squamous Cell Carcinoma.Laryngoscope. 2025 Feb;135(2):705-715. doi: 10.1002/lary.31794. Epub 2024 Sep 24. Laryngoscope. 2025. PMID: 39315470 Free PMC article.
-
Sinonasal Acinic Cell Carcinoma: A Review of the National Cancer Database.Am J Rhinol Allergy. 2022 Nov;36(6):741-746. doi: 10.1177/19458924221107206. Epub 2022 Jun 14. Am J Rhinol Allergy. 2022. PMID: 35702005 Review.
-
Survival Outcomes of De Novo vs Inverted Papilloma-Associated Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.JAMA Otolaryngol Head Neck Surg. 2021 Apr 1;147(4):350-359. doi: 10.1001/jamaoto.2020.5261. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33507208 Free PMC article.
Cited by
-
Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma.J Neurol Surg B Skull Base. 2022 Jun 6;84(3):232-239. doi: 10.1055/a-1780-4157. eCollection 2023 Jun. J Neurol Surg B Skull Base. 2022. PMID: 37187475 Free PMC article.
-
Nodal metastasis in surgically treated sinonasal squamous cell carcinoma.Discov Oncol. 2025 Jul 14;16(1):1328. doi: 10.1007/s12672-025-02899-0. Discov Oncol. 2025. PMID: 40658184 Free PMC article.
-
The Role of Regional Disease and Patterns of Treatment Failure in Primary Sinonasal Malignancies.Am J Rhinol Allergy. 2022 Jan;36(1):157-166. doi: 10.1177/19458924211033402. Epub 2021 Jul 22. Am J Rhinol Allergy. 2022. PMID: 34292084 Free PMC article.
-
Clinical study of poorly differentiated head and neck squamous cell carcinoma: a prospective cohort study in China.Ann Transl Med. 2022 Jun;10(12):703. doi: 10.21037/atm-22-2630. Ann Transl Med. 2022. PMID: 35845503 Free PMC article.
-
Phase II Trial of Neoadjuvant Docetaxel/Cisplatin/5-Fluorouracil Combined with Pegteograstim for Unresectable, Locally Advanced Sinonasal Squamous Cell Carcinoma: KCSG HN18-07.Cancer Res Treat. 2025 Jul;57(3):701-708. doi: 10.4143/crt.2024.1025. Epub 2024 Dec 16. Cancer Res Treat. 2025. PMID: 39701091 Free PMC article. Clinical Trial.
References
BIBLIOGRAPHY
-
- Cracchiolo JR, Patel K, Migliacci JC, et al. Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma. J Surg Oncol 2018;117:756-764. https://doi.org/10.1002/jso.24923.
-
- de Almeida JR, Su SY, Koutourousiou M, et al. Endonasal endoscopic surgery for squamous cell carcinoma of the sinonasal cavities and skull base: oncologic outcomes based on treatment strategy and tumor etiology. Head Neck 2015;37:1163-1169. https://doi.org/10.1002/hed.23731.
-
- Bossi P, Saba NF, Vermorken JB, et al. The role of systemic therapy in the management of sinonasal cancer: a critical review. Cancer Treat Rev 2015;41:836-843. https://doi.org/10.1016/j.ctrv.2015.07.004.
-
- Sanghvi S, Khan MN, Patel NR, Yeldandi S, Baredes S, Eloy JA. Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients. Laryngoscope 2014;124:76-83. https://doi.org/10.1002/lary.24264.
-
- Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 2012;34:877-885. https://doi.org/10.1002/hed.21830.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials